The U.S. government has authorized the sale and use of the first rapid test for the determination of fungal infection in the blood. The test was named T2Candida Panel. According to the developer, T2Candida Panel identifies Candida albicans, Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei.
In conventional medical practice for accurate diagnosis of fungal infections goes up to six days under the conditions of cultivation of the sample in the laboratory. If the fungus is rare, then the definition of extended additionally. T2Candida Panel capable of a few hours to identify one of the five most common species.
While it is difficult to talk about the rapid test as the main method for the diagnosis of fungal diseases. Doctors will also use the standard crops of biological samples. A parallel study will exclude the error of the new device.
Note, when testing test 1500 volunteers method showed 100% accuracy.